Vireo Growth Inc.
- Close
- Oct 29, 2026 · +2.33%
- Market cap
- $379.65M
- 48.06M shares
- Filings
- 373
Q3 2026+170.4% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+33.7% FY25 yoy
- $379.65M
- —
- 0.6×
- 0.8×
- -25.84%
- —
Twelve months to Sep 30, 2026 · derived
Price
Oct 29, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $268,769,268 | reported | |
| FY 2024 | 2024-12-31 | $99,384,221 | reported | |
| FY 2023 | 2023-12-31 | $88,133,163 | reported | |
| FY 2022 | 2022-12-31 | $74,625,867 | reported | |
| FY 2021 | 2021-12-31 | $54,446,168 | reported | |
| FY 2020 | 2020-12-31 | $49,211,329 | reported |
Segments
Products
LineFY2025ShareChange
Retail$219.93M82%+176.5%
Wholesale$48.84M18%+146.0%
Other———
Wholesale———
Total$268.77M
Pharmaceutical preparations
Vireo Growth Inc. is the 73rd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
RIGLRigel Pharmaceuticals Inc$294.3M64.1%124.7%$855.8MXERSXeris Biopharma Holdings, Inc.$291.8M43.7%0.2%$3.0BAUPHAurinia Pharmaceuticals Inc.$283.1M20.4%101.5%$2.2BHROWHarrow, Inc.$272.3M36.4%1.9%$1.1B
VREOFVireo Growth Inc. (this company)$268.8M170.4%25.3%$439.7M
LGNDLigand Pharmaceuticals Inc$268.1M60.4%46.4%$6.3BARVNArvinas, Inc.$262.6M0.3%30.8%$493.4MSDGRSchrodinger, Inc.$255.9M23.3%40.4%$2.3BRCUSArcus Biosciences, Inc.$247.0M4.3%142.9%$2.6BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Vireo Growth Inc. · CIK 1771706 · Engraved from SEC EDGAR